Skip to main content
. Author manuscript; available in PMC: 2022 Jul 5.
Published in final edited form as: Acta Diabetol. 2021 Feb 15;58(6):797–807. doi: 10.1007/s00592-021-01683-0

Table 1.

Characteristics of the study cohort

Overall (n = 15,848) PPDM (n = 1,132) T1DM (n = 3,396) T2DM (n = 11,320)

Age (years), mean (SD) 62.0 (16.4) 63.8 (16.1) 55.7 (16.7) 63.6 (15.9)
Women, n(%) 6,426 (40.5) 459 (40.5) 1,377 (40.5) 4,590 (40.5)
Ethnicity, n(%)
European 9,805 (61.9) 761 (67.2) 2,552 (75.2) 6,492 (57.4)
Māori or Pacific 4,087 (25.8) 297 (26.2) 576 (17.0) 3,214 (28.4)
Asian 1,304 (8.2) 56 (5.0) 153 (4.5) 1,095 (9.7)
Others 652 (4.1) 18 (1.6) 115 (3.4) 519 (4.6)
Social deprivation index, n(%)
Quartile 1 3,778 (23.8) 231 (20.4) 978 (28.8) 2,569 (22.7)
Quartile 2 4,388 (27.7) 331 (29.2) 970 (28.6) 3,087 (27.3)
Quartile 3 4,326 (27.3) 338 (29.9) 860 (25.3) 3,128 (27.6)
Quartile 4 2,483 (15.7) 190 (16.8) 380 (11.2) 1,913 (16.9)
Missing 873 (5.5) 42 (3.7) 208 (6.1) 623 (5.5)
Alcohol abuse, n(%) 532 (3.4) 179 (15.8) 120 (3.5) 233 (2.1)
Ever smoking, n(%) 8,376 (52.9) 764 (67.5) 1,763 (51.9) 5,849 (51.7)
Charlson comorbidity index, n (%)
1 8,201 (51.8) 585 (51.7) 1,716 (50.5) 5,900 (52.1)
2 1,662 (10.5) 143 (12.6) 190 (5.6) 1,329 (11.7)
3 3,012 (19.0) 179 (15.8) 746 (22.0) 2,087 (18.4)
≥ 4 2,973 (18.8) 225 (19.9) 744 (21.9) 2,004 (17.7)
Mortality, n (%)
Vascular 1,321 (8.3) 112 (9.9) 200 (5.9) 1,009 (8.9)
Cancer 1,106 (7.0) 107 (9.5) 179 (5.3) 820 (7.2)
Non-vascular non-cancer 2,335 (14.7) 207 (18.3) 503 (14.8) 1,625 (14.4)
All-cause 3,686 (23.3) 336 (29.7) 668 (19.7) 2,682 (23.7)
Mortality rate per 1,000 person-years (standard error)
Vascular 20.3 (0.6) 26.9 (2.6) 13.8 (1.0) 21.8 (0.7)
Cancer 17.0 (0.5) 25.7 (2.6) 12.4 (0.9) 17.7 (0.6)
Non-vascular non-cancer 36.0 (0.8) 49.8 (3.5) 34.8 (1.6) 35.1 (0.9)
All-cause 56.8 (1.0) 80.8 (4.7) 46.2 (1.8) 57.9 (1.2)

PPDM post-pancreatitis diabetes mellitus, T2DM type 2 diabetes mellitus, T1DM type 1 diabetes mellitus, SD standard deviation, 95% CI 95% confidence interval